Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 12, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs), rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific share transactions:
- Share Purchase Price: £12.24 per Ordinary Share (April 11, 2005).
- ADR Average Price: $46.00 (April 8, 2005).
Material Changes
The filing details the following changes in equity interests:
- Director Acquisition: Mr. J S Heslop acquired 20 Ordinary Shares (10 via personal contribution and 10 via company matching) under the ShareReward Plan on April 11, 2005.
- Trust Transfers: The GlaxoSmithKline Employee Trust transferred 18,492 Ordinary Shares on April 11, 2005, and 2,000 Ordinary Shares on February 18, 2005, to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Retirement Fund Movement: The GlaxoSmithKline US Retirement Savings Plan saw its holdings increase from 18,292,789 to 18,341,531 Ordinary Share ADRs due to fund movements on April 8, 2005.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items. The document is strictly limited to reporting statutory changes in director and employee trust shareholdings.
Investor Verification Checklist
- Verify the total number of shares held by directors Dr. J-P Garnier, Dr. T Yamada, and Mr. J S Heslop following these transactions.
- Confirm the impact of the ShareReward Plan matching contribution on the company's compensation expenses.
- Review the full terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand vesting schedules for the transferred shares.
- Check subsequent filings for the company's actual financial performance for the quarter or fiscal year, as this document contains no operational metrics.